Calithera Biosciences, Inc. (NASDAQ:CALA – Get Free Report)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.01 and traded as low as $0.00. Calithera Biosciences shares last traded at $0.00, with a volume of 407 shares changing hands.
Analysts Set New Price Targets
Separately, StockNews.com assumed coverage on Calithera Biosciences in a report on Saturday. They issued a “hold” rating for the company.
Read Our Latest Report on CALA
Calithera Biosciences Stock Up 20.0 %
Calithera Biosciences Company Profile
Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.
Further Reading
- Five stocks we like better than Calithera Biosciences
- How to Buy Cheap Stocks Step by Step
- Is Myers Industries Poised for a Breakout?
- What is the S&P/TSX Index?
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- Growth Stocks: What They Are, Examples and How to Invest
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
